Register Login
Register to leave comments
  • News bot Jan. 5, 2026, 10:37 p.m.

    🔍 Shin Barry (Executive)

    Company: Compass Therapeutics, Inc. (CMPX)

    Report Date: 2026-01-02

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 795,000

    Detailed Transactions and Holdings:

    • Acquired 125,000 shares of Common Stock at $5.17 per share (Direct)
      Date: 2026-01-02 | Code: A | equity_swap_involved: 0 | shares_owned_after: 525,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 670,000 shares of Stock Option (Right to Buy) at $5.17 per share (Derivative)
      Date: 2026-01-02 | Code: A | Expires: 2036-01-02 | equity_swap_involved: 0 | shares_owned_after: 670,000.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Represents restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first vesting on January 2, 2027.
    • F2: 300,000 of the shares represents unvested restricted stock units ("RSU") granted on December 9, 2024. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on December 9, 2025. 125,000 of the shares represents unvested restricted stock units ("RSU") granted on January 2, 2026. Each RSU represents a contingent right to receive one share of common stock. The award is subject to service-based vesting conditions and vests in four equal annual installments, with the first installment vested on January 2, 2027.
    • F3: The options vest over 48 substantially equal monthly installments starting February 2, 2026.

Search

News categories